Related Experiment Video

Updated: Jun 17, 2026

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
11:56

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

Published on: September 28, 2017

Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer

Brittney Jung-Hynes1, Russel J Reiter, Nihal Ahmad

  • 1Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA.

Journal of Pineal Research
|December 23, 2009
PubMed

Insights

This review explores the link between sirtuins (class III HDACs), melatonin, and circadian rhythms. These factors are implicated in aging, cancer, and chronotherapy, suggesting potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Chronobiology

Background:

  • Sirtuins (class III HDACs) are increasingly studied for roles in aging and cancer.
  • Melatonin, a pineal hormone, influences circadian rhythms and has anti-cancer properties.
  • Circadian rhythm disruptions are linked to aging and increased cancer risk.

Purpose of the Study:

  • To review the interconnectedness of sirtuins, melatonin, and circadian rhythms.
  • To explore their combined implications in aging, cancer, and chronomodulation.
  • To highlight potential therapeutic applications in chronotherapy.

Main Methods:

  • Literature review of studies on sirtuins, melatonin, and circadian rhythms.
  • Analysis of molecular mechanisms linking these pathways.
  • Synthesis of evidence regarding their roles in aging and cancer.

Main Results:

  • SIRT1 is linked to carcinogenesis and circadian machinery.
  • Melatonin exhibits anti-cancer effects and is tied to circadian genes.
  • SIRT1 interacts with circadian pathways via deacetylation and NAD+ salvage.

Conclusions:

  • A potential connection exists between sirtuins, melatonin, and circadian circuitry.
  • This interplay is relevant to aging, cancer development, and treatment strategies.
  • Further research may uncover novel therapeutic targets for age-related diseases and cancer.

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...